ISSN: 2684-1266
+44-77-2385-9429
Department of Oncology, Harvard University, Cambridge, USA
Perspective
Customising Cancer Immunotherapy: Adapting Therapy to the Patient and the Tumor
Author(s): Fenglin Xinyue*
DOI:
10.35248/2684-1266.24.10.232